Postabortion Contraception: Qualitative Interviews On Counseling and Provision of Long-Acting Reversible Contraceptive Methods

Perspectives on Sexual and Reproductive Health

Volumn 44, Issue 2, 2012, Pages 100-106

  Morse, Jessica ^a   Freedman, Lori ^a   Speidel, J Joseph ^a   Thompson, Kirsten M J ^a   Stratton, Laura ^a   Harper, Cynthia C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTRACEPTION; COUNSELING; DOCTOR PATIENT RELATION; FAMILY PLANNING; FEMALE; HEALTH EDUCATION; HEALTH PERSONNEL ATTITUDE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PREGNANCY; STATISTICS; UNITED STATES; UNPLANNED PREGNANCY;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; COUNSELING; FAMILY PLANNING SERVICES; FEMALE; HEALTH EDUCATION; HUMANS; INTRAUTERINE DEVICES, MEDICATED; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; PREGNANCY, UNPLANNED; UNITED STATES;

EID: 84862124488     PISSN: 15386341     EISSN: 19312393     Source Type: Journal    
DOI: 10.1363/4410012     Document Type: Article

References (29)

1. Singh S, Sedgh G and Hussain R, Unintended pregnancy: worldwide levels, trends, and outcomes, Studies in Family Planning, 2010, 41(4):241-250.
2. Finer LB and Henshaw SK, Disparities in rates of unintended pregnancy in the United States, 1994 and 2001, Perspectives on Sexual and Reproductive Health, 2006, 38(2):90-96.
3. Creinin MD, Conception rates after abortion with methotrexate and misoprostol, International Journal of Gynecology & Obstetrics, 1999, 65(2):183-188.
4. Goldberg AB et al., Post-abortion depot medroxyprogesterone acetate continuation rates: a randomized trial of cyclic estradiol, Contraception, 2002, 66(4):215-220.
5. Centers for Disease Control and Prevention, U.S. medical eligibility criteria for contraceptive use, 2010, Morbidity and Mortality Weekly Report Early Release, 2010, Vol. 59.
6. World Health Organization (WHO), Medical Eligibility Criteria for Contraceptive Use, third ed., Geneva: WHO, 2004.
7. Grimes D, Schulz K and Stanwood N, Immediate postabortal insertion of intrauterine devices, Cochrane Database of Systematic Reviews, 2002, Issue 3, No. CD001777.
8. Stanek AM et al., Barriers associated with the failure to return for intrauterine device insertion following first-trimester abortion, Contraception, 2009, 79(3):216-220.
9. Heikinheimo O, Gissler M and Suhonen S, Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion, Contraception, 2008, 78(2):149-154.
10. Ames CM and Norman WV, Preventing repeat abortion in Canada: Is the immediate insertion of intrauterine devices postabortion a cost-effective option associated with fewer repeat abortions? Contraception, 2012, 85(1):51-55.
11. Reeves MF, Smith KJ and Creinin MD, Contraceptive effectiveness of immediate compared with delayed insertion of intrauterine devices after abortion: a decision analysis, Obstetrics & Gynecology, 2007, 109(6):1286-1294.
12. Kavanaugh ML, Jones RK and Finer LB, How commonly do US abortion clinics offer contraceptive services? Contraception, 2010, 82(4):331-336.
13. Thompson KM et al., Contraceptive policies affect post-abortion provision of long-acting reversible contraception, Contraception, 2011, 83(1):41-47.
14. Whitaker AK et al., Adolescent and young adult women's knowledge of and attitudes toward the intrauterine device, Contraception, 2008, 78(3):211-217.
15. Hladky KJ et al., Women's knowledge about intrauterine contraception, Obstetrics & Gynecology, 2011, 117(1):48-54.
16. Fleming KL, Sokoloff A and Raine TR, Attitudes and beliefs about the intrauterine device among teenagers and young women, Contraception, 2010, 82(2):178-182.
17. Harper CC et al., Challenges in translating evidence to practice: the provision of intrauterine contraception, Obstetrics & Gynecology, 2008, 111(6):1359-1369.
18. Henshaw SK and Finer LB, The accessibility of abortion services in the United States, 2001, Perspectives on Sexual and Reproductive Health, 2003, 35(1):16-24.
19. Jones RK et al., Abortion in the United States: incidence and access to services, 2005, Perspectives on Sexual and Reproductive Health, 2008, 40(1):6-16.
20. Frost JJ, Singh S and Finer LB, U.S. women's one-year contraceptive use patterns, 2004, Perspectives on Sexual and Reproductive Health, 2007, 39(1):48-55.
21. Vaughan B et al., Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth, Contraception, 2008, 78(4):271-283.
22. Raine TR et al., One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives, Obstetrics & Gynecology, 2011, 117(2 Pt. 1):363-371.
23. Jones RK and Kooistra K, Abortion incidence and access to services in the United States, 2008, Perspectives on Sexual and Reproductive Health, 2011, 43(1):41-50.
24. Jones RK, Finer LB and Singh S, Characteristics of U.S. Abortion Patients, 2008, New York: Guttmacher Institute, 2010.
25. Cohen S, Repeat abortion, repeat unintended pregnancy, repeated and misguided government policies, Guttmacher Policy Review, 2007, 10(2):8-12.
26. Secura GM et al., The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception, American Journal of Obstetrics & Gynecology, 2010, 203(2):115.e1-115.e7, accessed Apr. 9, 2012.
27. Trussell J, The cost of unintended pregnancy in the United States, Contraception, 2007, 75(3):168-170.
28. Foster DG et al., Cost savings from the provision of specific methods of contraception in a publicly funded program, American Journal of Public Health, 2009, 99(3):446-451.
29. Trussell J et al., Cost effectiveness of contraceptives in the United States, Contraception, 2009, 79(1):5-14.